Literature DB >> 22323574

Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD.

David A McAllister1, John D Maclay, Nicholas L Mills, Andrew Leitch, Philip Reid, Ross Carruthers, Jennifer O'Connor, Lawrence McAlpine, George Chalmers, David E Newby, Elaine Clark, Peter W Macfarlane, William Macnee.   

Abstract

Cardiovascular disease is common in chronic obstructive pulmonary disease (COPD) and raised troponin is common in exacerbations. However, the prevalence of myocardial infarction following hospitalisation for exacerbation of COPD is unknown. Patients aged ≥ 40 yrs hospitalised with acute exacerbation of COPD (n = 242) with ≥ 10 pack-yrs of cigarette smoking were included in a prospective case series conducted in four hospitals. Patients whose primary presenting complaint was chest pain or who had an alternative diagnosis were excluded. Chest pain histories, serial ECGs and troponin levels were obtained. The mean ± SD age was 69 ± 9 yrs; 108 (45%) patients were male and almost half were current smokers. 124 (51%; 95% CI 48-58%) patients had chest pain, which was exertional in 62 (26%). 24 (10%) had raised troponin, among whom, 20 (8.3%; 95% CI 5.1-12.5%) had chest pain and/or serial ECG changes, fulfilling the 2007 Universal Definition of Myocardial Infarction. Neither chest pain (p = 0.77) nor serial ECG changes (p = 0.39) were associated with raised troponin. Raised troponin, chest pain and serial ECG changes are common in patients admitted to hospital with exacerbation of COPD. Overall, one in 12 patients met the criteria for myocardial infarction. Whether these patients would benefit from further cardiac investigation is unknown.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22323574     DOI: 10.1183/09031936.00124811

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

1.  Impact of Left Ventricular Hypertrophy on Survival in Chronic Obstructive Pulmonary Disease.

Authors:  Philip M Short; William J Anderson; Douglas H J Elder; Allan D Struthers; Brian J Lipworth
Journal:  Lung       Date:  2015-03-29       Impact factor: 2.584

Review 2.  Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns.

Authors:  Alvar Agustí; Peter M Calverley; Marc Decramer; Robert A Stockley; Jadwiga A Wedzicha
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

3.  [Pulmonary causes of chest pain].

Authors:  B Jany
Journal:  Internist (Berl)       Date:  2017-01       Impact factor: 0.743

Review 4.  Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.

Authors:  Chad Wade; J Michael Wells
Journal:  Expert Rev Respir Med       Date:  2020-04-19       Impact factor: 3.772

5.  A decision tree to assess short-term mortality after an emergency department visit for an exacerbation of COPD: a cohort study.

Authors:  Cristóbal Esteban; Inmaculada Arostegui; Susana Garcia-Gutierrez; Nerea Gonzalez; Iratxe Lafuente; Marisa Bare; Nerea Fernandez de Larrea; Francisco Rivas; José M Quintana
Journal:  Respir Res       Date:  2015-12-22

Review 6.  The bidirectional relationship between chronic obstructive pulmonary disease and coronary artery disease.

Authors:  Ayham Daher; Michael Dreher
Journal:  Herz       Date:  2020-04       Impact factor: 1.443

7.  Evaluation of Pregnancy-Associated Plasma Protein-A Levels in Patients with Chronic Obstructive Pulmonary Disease and Associations with Disease Severity.

Authors:  Fahrettin Talay; Mehmet Tosun; Zehra Asuk Yaşar; Özlem Kar Kurt; Aysel Karği; Serkan Öztürk; Mehmet Fatih Özlü; Aytekin Alçelik
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

8.  Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD.

Authors:  J Michael Wells; Joshua B Morrison; Surya P Bhatt; Hrudaya Nath; Mark T Dransfield
Journal:  Chest       Date:  2016-01-12       Impact factor: 9.410

9.  Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Kieran J Rothnie; Olivia Connell; Hana Müllerová; Liam Smeeth; Neil Pearce; Ian Douglas; Jennifer K Quint
Journal:  Ann Am Thorac Soc       Date:  2018-08

10.  Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.

Authors:  Anant R C Patel; Beverly S Kowlessar; Gavin C Donaldson; Alex J Mackay; Richa Singh; Siobhan N George; Davinder S Garcha; Jadwiga A Wedzicha; John R Hurst
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.